hospitalization – mycolab.ai

A sense of the bigger picture: A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use

mycolabadmin

This research explored how 15 people with bipolar disorder who used psilocybin mushrooms experienced the effects. Many reported benefits like reduced depression and improved outlook on life, but some experienced negative effects including sleep problems and increased manic episodes. The study identified important factors that influenced outcomes, such as whether people used other drugs simultaneously, whether they used psilocybin alone or with others, and how much sleep they had before use. The researchers concluded that while psilocybin shows promise for bipolar depression, more careful clinical research is needed to ensure safety.

Online Availability of Diamond Shruumz Before and After FDA Recall Initiation: Qualitative Assessment and Simulated Test Purchasing

mycolabadmin

Diamond Shruumz mushroom-based edible products caused severe illnesses in consumers and were recalled by the FDA in June 2024. Researchers discovered that despite the recall, many online sellers continued to advertise and sell these products across social media and websites. The study found that even two weeks after the recall, about one-third of the websites still successfully completed product sales, showing how difficult it is for regulators to enforce recalls on the internet.

Anti-Therapeutic Action: hospitalization

A sense of the bigger picture: A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use

Online Availability of Diamond Shruumz Before and After FDA Recall Initiation: Qualitative Assessment and Simulated Test Purchasing